Market Place
Sourcing Support
Tiefenbacher API+ Ingredients Offers Custom Synthesis Of Intermediates & Apis
08 May 2024 //
PRESS RELEASE
Tiefenbacher Group welcome our new COO for AET Laboratories, Sandip Tarate
08 Apr 2024 //
PRESS RELEASE
Tiefenbacher Group awarded the EcoVadis Silver Medal!
19 Mar 2024 //
PRESS RELEASE
Tiefenbacher Pharmaceuticals Launch Of Generic Teriflunomide
27 Sep 2023 //
PRESS RELEASE
Successful Approval of manufacturing and laboratory facilities by Saudi Food and Drug Authority
10 May 2023 //
PRESS RELEASE
Tiefenbacher Pharma Successfully Launches The Antihistamine Bilastine
14 Mar 2023 //
PRESS RELEASE
Tiefenbacher Manufacturing Sites Have Been Successfully Registered By The UAE
25 Feb 2023 //
PRESS RELEASE
Tiefenbacher Successfully Launches Generic Version Of The Psoriasis Apremilast
01 Dec 2022 //
PRESS RELEASE
Four Drugs Recommended For Approval By Chmp At April Meeting
25 Apr 2022 //
MEDWATCH
Tiefenbacher API + Ingredients Secures The Supply Of Controlled Substances For Customers And Patients
22 Jun 2021 //
PRESS RELEASE
Tiefenbacher API + Ingredients Offers Pitavastatine Calcium For Novel Therapies
11 May 2021 //
PRESS RELEASE
Tiefenbacher API + Ingredients Starts To Offer The First Api Based On Green Chemistry
15 Apr 2021 //
PRESS RELEASE
What Trends Driving The Adalimumab Biosimilar Market? Global Key Players
19 May 2020 //
OPENPR
What Driving Adalimumab Biosimilar Market? Top Players Alfred E. Tiefenbacher,
09 Mar 2020 //
OPENPR
Global Fampridine Market Research Strategies and Forecasts, 2020 to 2025
08 Mar 2020 //
BCCOURIER
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.